Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, South Korea.
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Front Endocrinol (Lausanne). 2022 Oct 20;13:976056. doi: 10.3389/fendo.2022.976056. eCollection 2022.
This study evaluated the association between metabolic health status and incident kidney cancer among obese participants.
A total of 514,866 individuals were included from the Korean National Health Insurance Service-National Health Screening Cohort. Changes in metabolic health status and obesity from the baseline examination in 2009-2010 to the next biannual examination in 2011-2012 were determined. Based on the status change, obese participants were divided into four groups: stable metabolically healthy obesity, metabolically healthy obesity to metabolically unhealthy obesity, metabolically unhealthy obesity to metabolically healthy obesity, and stable metabolically unhealthy obesity.
The stable metabolically healthy obesity phenotype did not confer an increased risk of incident kidney cancer, compared to the stable metabolically healthy non-obese group. In contrast, the metabolically healthy obesity to metabolically unhealthy obesity group had a significantly higher risk of incident kidney cancer than the stable metabolically healthy non-obese group. Among patients with metabolically unhealthy obesity at baseline, those who transitioned to the metabolically healthy obese group had no increased risk of kidney cancer, whereas those who remained in metabolically unhealthy obesity status had a higher risk of incident kidney cancer than the stable metabolically healthy non-obese group. The transition or maintenance of metabolic health was a decisive factor for kidney cancer in obese patients.
Maintaining or restoring metabolic health should be stressed upon in obese patients to reduce the risk of kidney cancer.
本研究评估了代谢健康状况与肥胖参与者发生肾癌之间的关联。
共纳入 514866 名来自韩国国家健康保险服务-国家健康筛查队列的参与者。从 2009-2010 年的基线检查到 2011-2012 年的下一次每两年一次的检查,确定了代谢健康状况和肥胖的变化。根据状态变化,肥胖参与者被分为四组:稳定的代谢健康肥胖、代谢健康肥胖到代谢不健康肥胖、代谢不健康肥胖到代谢健康肥胖以及稳定的代谢不健康肥胖。
与稳定的代谢健康非肥胖组相比,稳定的代谢健康肥胖表型不会增加肾癌的发病风险。相比之下,代谢健康肥胖到代谢不健康肥胖组发生肾癌的风险明显高于稳定的代谢健康非肥胖组。在基线时患有代谢不健康肥胖的患者中,那些转变为代谢健康肥胖组的患者没有增加肾癌的风险,而那些仍处于代谢不健康肥胖状态的患者发生肾癌的风险高于稳定的代谢健康非肥胖组。代谢健康的转变或维持是肥胖患者发生肾癌的决定性因素。
肥胖患者应强调保持或恢复代谢健康,以降低肾癌的风险。